USC physician Anne L. Peters receives American Diabetes Association's Distinguished Clinician Award

June 09, 2008

San Francisco, CA (June 9, 2008) - The American Diabetes Association (ADA), the nation's leading voluntary health organization in the fight against diabetes, announced today that Anne L. Peters, MD, CDE, received the Association's prestigious Outstanding Physician Clinician Award at the organization's 68th Scientific Sessions. Peters is the director of the Westside Center for Diabetes at the University of Southern California and a professor of clinical medicine at the Keck School of Medicine of USC.

The Outstanding Physician Clinician Award is presented to an individual who has made outstanding efforts in diabetes care and is recognized as a highly regarded clinician and educator with more than 10 years of distinguished service.

"On behalf of the American Diabetes Association, we are delighted to present this prestigious award to Dr. Peters," said John Buse, MD, PhD, President, Medicine & Science, of the American Diabetes Association. "Her contributions to the diabetes community and dedication to diabetes care directly support ADA's mission to prevent and cure diabetes and to improve the lives of all people living with diabetes."

Peters manages two diabetes centers, one in the Beverly Hills area and one in the underserved, primarily Latino East Los Angeles, which was highlighted in the PBS series "Remaking American Medicine." She also participates in community-based diabetes and obesity prevention initiatives.

"This is a well deserved award," says Thomas A. Buchanan, M.D. Chief of the Division of Endocrinology and Diabetes at the Keck School of Medicine of USC. "Dr. Peters is one hundred percent dedicated to improving the lives of diabetes patients and one of the leaders of USC diabetes research and care, helping to translate research findings into clinical care."

Dr. Peters' research is focused on improving the delivery of medical care to patients with diabetes, particularly in underserved populations. She is the principal investigator on several diabetes clinical trials, including a grant from the California Nutrition Network, and the National Institutes of Health-funded Look AHEAD (Action for Health in Diabetes) study. She is involved in numerous professional organizations and activities, and has written over 100 publications, including Conquering Diabetes, published by Penguin Books, and Davidson's Diabetes Mellitus, Fifth Edition. She serves on the editorial board for ADA's Diabetes Care, is a reviewer for multiple journals and is on the ABIM Endocrinology and Diabetes Board. ADA-Outstanding Physician Clinician Award/Page 2

"I am very honored to receive this award in part because of who I'm compared to," says Peters "At USC, working with patients from both West Los Angeles and the underserved population has given me such a diverse experience, which is really unique."

More than 13,000 top scientists, physicians and other health care professionals from around the world shared cutting-edge research, treatment recommendations and advances toward a cure for diabetes at the Association's 68th Scientific Sessions in San Francisco, CA.
-end-
Diabetes is a serious disease that affects the body's ability to produce or respond properly to insulin, a hormone that allows blood sugar to enter the cells of the body and be used for energy. Nearly 21 million children and adults in the United States have diabetes. An additional 54 million have pre-diabetes. Diabetes is the fifth leading cause of death by disease in the United States and it has no cure.

The American Diabetes Association is the nation's premier voluntary health organization supporting diabetes research, information and advocacy. The Association's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Founded in 1940, the Association provides services to hundreds of communities across the country. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

University of Southern California

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.